Non-Executive Director and Chairman

Frederick Bart

Frederick (Fred) Bart joined the Board and was appointed Chair in January 2024.

Fred has extensive local and international experience in directorial and board roles, and through his organisation, The Bart Group, chairs multiple private companies ranging across the hotel, retail, land development and technology sectors.

He currently holds positions with multiple ASX-listed companies, including Audio Pixels Holdings Limited (ASX: AKP), which boasts a market capitalisation of over $248m and is developing the world’s first digital speaker; and Noxopharm Limited (ASX: NOX), a pre-clinical Biotech company developing novel treatments for cancer and inflammation. Fred previously held positions with Electro Optics Systems Holdings Limited (ASX: EOS), one of Australia’s leading defence companies and currently in the S&P/ASX 300; and Weebit Nano Limited (ASX: WBT), a developer of cutting-edge flash memory technology.

In recent years, Fred has become chairman and majority shareholder of Immunovative Therapies Limited, a private Israeli developer of vaccines for certain forms of cancer, and in 2020 joined the board of Noxopharm Limited (ASX: NOX).

Read More

Non-Executive Director and Chairman

Frederick Bart

Frederick (Fred) Bart joined the Board and was appointed Chair in January 2024.

Fred has extensive local and international experience in directorial and board roles, and through his organisation, The Bart Group, chairs multiple private companies ranging across the hotel, retail, land development and technology sectors.

He currently holds positions with multiple ASX-listed companies, including Audio Pixels Holdings Limited (ASX: AKP), which boasts a market capitalisation of over $248m and is developing the world’s first digital speaker; and Noxopharm Limited (ASX: NOX), a pre-clinical Biotech company developing novel treatments for cancer and inflammation. Fred previously held positions with Electro Optics Systems Holdings Limited (ASX: EOS), one of Australia’s leading defence companies and currently in the S&P/ASX 300; and Weebit Nano Limited (ASX: WBT), a developer of cutting-edge flash memory technology.

In recent years, Fred has become chairman and majority shareholder of Immunovative Therapies Limited, a private Israeli developer of vaccines for certain forms of cancer, and in 2020 joined the board of Noxopharm Limited (ASX: NOX).

Non-Executive Director

Shawn Van Boheemen

Shawn van Boheemen joined the Board in January 2024.

Shawn’s experience in commercial finance leadership spans 30 years across various sectors, including healthcare, manufacturing, biotech and financial services.

His expertise includes Australian ASX and ASIC reporting, SEC reporting in the USA, compliance and regulatory affairs, internal and external audit work, taxation, business and financial analytics, IP protection, as well as regulatory and financial reporting locally and in the United States.

He has held senior financial positions in both Australian and multinational organisations, including Covance, Unomedical, M.D. Sass, and New York Life Insurance. He is currently CFO of Noxopharm Limited (ASX: NOX) and CFO/Company Secretary of Audio Pixels Holdings Limited (ASX: AKP).

Shawn holds a Master of Commerce degree with a major in Accounting (UWS) and a Bachelor of Business degree in Accounting and Commercial Law (UWS). He is a Fellow of the Australian Society of Certified Practising Accountants and a Justice of the Peace in NSW.

Read More

Non-Executive Director

Shawn Van Boheemen

Shawn van Boheemen joined the Board in January 2024.

Shawn’s experience in commercial finance leadership spans 30 years across various sectors, including healthcare, manufacturing, biotech and financial services.

His expertise includes Australian ASX and ASIC reporting, SEC reporting in the USA, compliance and regulatory affairs, internal and external audit work, taxation, business and financial analytics, IP protection, as well as regulatory and financial reporting locally and in the United States.

He has held senior financial positions in both Australian and multinational organisations, including Covance, Unomedical, M.D. Sass, and New York Life Insurance. He is currently CFO of Noxopharm Limited (ASX: NOX) and CFO/Company Secretary of Audio Pixels Holdings Limited (ASX: AKP).

Shawn holds a Master of Commerce degree with a major in Accounting (UWS) and a Bachelor of Business degree in Accounting and Commercial Law (UWS). He is a Fellow of the Australian Society of Certified Practising Accountants and a Justice of the Peace in NSW.

Non-Executive Director

Graeme Newing

Graeme Newing joined the board in January 2024

He was a securities analyst within the stockbroking industry for some decades before his retirement. He was the top rated mining analyst for most of the 1980s, at JM Bowyer and Co and then at County Natwest Securities Australia where he became a director.

Graeme holds a BSc (Hons 1) in Mineral Technology from Otago University. Before joining the stockbroking industry he was employed as a Mining Engineer at the Rosebery mine in Tasmania.

 

Non-Executive Director

Graeme Newing

Graeme Newing joined the board in January 2024

He was a securities analyst within the stockbroking industry for some decades before his retirement. He was the top rated mining analyst for most of the 1980s, at JM Bowyer and Co and then at County Natwest Securities Australia where he became a director.

Graeme holds a BSc (Hons 1) in Mineral Technology from Otago University. Before joining the stockbroking industry he was employed as a Mining Engineer at the Rosebery mine in Tasmania.

 

Find out more about PET

Contact Us